Health & Science

Weight-Loss Drugs Used in Nearly One in 10 Great Britain Homes, Study Finds

· GlobeWire Daily Science Desk · Source: www.theguardian.com

2 min read

Key takeawaysAccording to research by Worldpanel by Numerator, weight-loss medications are now used by at least one person in 8.5% of households across Great Britain. The findings indicate that approximately 2.6 million adults were using these medications by August, reflecting an increase of about 700,000 users since February. Analysts attribute this growth to…
Weight-loss drugs used in nearly one in 10 homes in Great Britain, study finds

Image: the Guardian · Photo source · Resized and letterboxed to 16:9; no AI generation

According to research by Worldpanel by Numerator, weight-loss medications are now used by at least one person in 8.5% of households across Great Britain. The findings indicate that approximately 2.6 million adults were using these medications by August, reflecting an increase of about 700,000 users since February. Analysts attribute this growth to factors such as the regulatory approval of pill versions and rising participation among male users.

Survey Findings and Household Reach

Data from the survey of more than 9,600 households outline several key figures regarding the prevalence and demographics of GLP-1 users:

  • Household penetration rose from 6.3% in February to 8.5% in August.
  • Men accounted for 32% of users by August, up from 23% in February, with male users nearly doubling to 830,000.
  • Pills accounted for 11.2% of GLP-1 users following the UK approval of weight-loss pills such as Wegovy in June.
  • Researchers noted that GLP-1 users are now found in a comparable share of households to buyers of branded items like Kellogg’s Rice Krispies (8.6%) and Corona beer (8.4%).

Impact on Grocery Spending and Purchasing Habits

The research reported that the increased use of drugs such as Mounjaro and Wegovy coincides with shifts in supermarket buying habits and reduced overall grocery spending.

  • Households with a GLP-1 user collectively spent £1 billion less on groceries than expected over a one-year period compared with similar households.
  • The reduction translates to roughly 415 million fewer items bought, or an average of £389 displaced per year from shopping baskets.
  • Categories associated with indulgence and impulse purchases saw declines, including a 15% greater drop in alcohol spending compared to non-GLP-1 households, and a similar fall in crisp purchases due to reduced snacking.
  • Conversely, portion-controlled and specific treat items saw growth, including a 30% rise in frozen ready-meals sold and increased spending on hot chocolate and malt drinks.

Expert Commentary and Future Estimates

Nishita Pattni, a senior consultant for Worldpanel by Numerator, stated that user numbers rose almost as much between February and August 2026 as they did in the previous full year, driven by the convenience of daily pills over injections and rising male interest. Chantel Kennaugh, head of public sector and nutrition at Worldpanel, estimated that usage could surpass 10% of households in Great Britain in 2027, describing the shift as a significant change for retailers and manufacturers.

Readers can verify original industry announcements and market research reports directly through the Worldpanel by Numerator platform or related consumer market publications.

Share this article
Read the original source: Weight-loss drugs used in nearly one in 10 homes in Great Britain, study finds

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Science Desk — AI-assisted news based on attributed published sources.

More to read